Evolutionary landscape and collaborative networks of global theranostic research in nuclear medicine: a visual bibliometric analysis

BACKGROUND: Theranostics, integrating diagnostic imaging with targeted radionuclide therapy, has become central to nuclear medicine, but its global research landscape and collaboration patterns remain incompletely mapped. OBJECTIVE: To characterize publication dynamics, cooperative networks, and emerging topics in theranostic research from 2006 to 2024. METHODS: Articles and reviews indexed in the Web of Science Core Collection were retrieved for bibliometric analysis. Excel, CiteSpace, VOSviewer, Scimago Graphica, ArcGIS, and the R package bibliometrix were used for quantitative analysis and visualization. RESULTS: A total of 1801 articles and reviews were included, with a compound annual growth rate of 18.7%. The USA, Germany, and China were the leading producer countries, and the USA-Germany collaboration showed the strongest bilateral link strength. The Helmholtz Association, Memorial Sloan Kettering Cancer Center, and the University of California System were the most productive institutions, while Herrmann K., Wester H.J., and Werner R.A. led individual output. Keyword co-occurrence analysis identified five major themes: prostate-specific membrane antigen (PSMA)-targeted imaging and therapy, somatostatin receptor-based peptide therapy, neuroendocrine tumors, alpha-particle therapy, and fibroblast activation protein-targeted probes. Burst detection showed that fibroblast activation protein, actinium-225, and 177Lu-PSMA-617 have emerged as recent research hotspots. CONCLUSION: Theranostic research in nuclear medicine has expanded rapidly over the past two decades, with a trans-Atlantic and Asia-Pacific collaborative pattern. Current frontiers are shifting from beta-emitters toward alpha-emitters and tumor-microenvironment-targeted probes. Greater intercontinental cooperation and continued focus on novel radionuclides and under-explored targets may support future innovation and clinical translation.

Authors

Institutions

Publication Details

Journal
Nuclear Medicine Communications
Published
2026-05-22
DOI
https://doi.org/10.1097/mnm.0000000000002183
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evolutionary landscape and collaborative networks of global theranostic research in nuclear medicine: a visual bibliometric analysis

Ying-nan Jia, Pei-hui Liu, Qian Wu
Nuclear Medicine Communications
Radiopharmaceutical Chemistry and Applications
article

Evolutionary landscape and collaborative networks of global theranostic research in nuclear medicine: a visual bibliometric analysis

Ying-nan Jia, Pei-hui Liu, Qian Wu
article en

Abstract

BACKGROUND: Theranostics, integrating diagnostic imaging with targeted radionuclide therapy, has become central to nuclear medicine, but its global research landscape and collaboration patterns remain incompletely mapped. OBJECTIVE: To characterize publication dynamics, cooperative networks, and emerging topics in theranostic research from 2006 to 2024. METHODS: Articles and reviews indexed in the Web of Science Core Collection were retrieved for bibliometric analysis. Excel, CiteSpace, VOSviewer, Scimago Graphica, ArcGIS, and the R package bibliometrix were used for quantitative analysis and visualization. RESULTS: A total of 1801 articles and reviews were included, with a compound annual growth rate of 18.7%. The USA, Germany, and China were the leading producer countries, and the USA-Germany collaboration showed the strongest bilateral link strength. The Helmholtz Association, Memorial Sloan Kettering Cancer Center, and the University of California System were the most productive institutions, while Herrmann K., Wester H.J., and Werner R.A. led individual output. Keyword co-occurrence analysis identified five major themes: prostate-specific membrane antigen (PSMA)-targeted imaging and therapy, somatostatin receptor-based peptide therapy, neuroendocrine tumors, alpha-particle therapy, and fibroblast activation protein-targeted probes. Burst detection showed that fibroblast activation protein, actinium-225, and 177Lu-PSMA-617 have emerged as recent research hotspots. CONCLUSION: Theranostic research in nuclear medicine has expanded rapidly over the past two decades, with a trans-Atlantic and Asia-Pacific collaborative pattern. Current frontiers are shifting from beta-emitters toward alpha-emitters and tumor-microenvironment-targeted probes. Greater intercontinental cooperation and continued focus on novel radionuclides and under-explored targets may support future innovation and clinical translation.

Nuclear Medicine Communications
Hue Central Hospital (VN), Xuzhou Central Hospital (CN)
Partnerships for the goals, Industry, innovation and infrastructure
Openalex Percentile: Top 5%
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.